PHILADELPHIA, July 10, 2025 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating National HealthCare Corporation (NYSE: NHC) ("NHC") on behalf of the company's long-term investors. Since November 2024, shares of NHC's common stock have declined in value from a trading price of over $135.00 per share to a current trading price of below $110.00 per share, a decline of nearly 20% in value. The investigation seeks to determine whether NHC and/or the company's officers and directors violated the se ...

Editor's note: Seeking Alpha is proud to welcome James O'Grady as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.I practiced in a medical field for 12 years before achieving financial independence in 2017. I focus on researching under the radar companies that get little analyst coverage. I am primarily interested in finding opportunities in defensive se ...

NHC Q1 2025 Earnings Release [Financial Highlights](index=1&type=section&id=Financial%20Highlights) National HealthCare Corporation (NHC) reported strong financial results for the first quarter of 2025, with net operating revenues increasing **25.7%** year-over-year to **$373.7 million**, driven by the August 2024 acquisition of White Oak Management, Inc. and an **8.5%** increase in same-facility revenues, leading to significant increases in both GAAP and adjusted net income, with adjusted net income growing by **61.4%** to **$24.8 million** Q1 2025 vs Q1 2024 Key Financial Metrics | Metric | Q1 2025 ($ millions) | Q1 2024 ($ millions) | Change | | :--- | :--- | :--- | :--- | | Net Operating Revenues | $373.7 | $297.2 | +25.7% | | GAAP Net Income | $32.2 | $26.2 | +22.9% | | Adjusted Net Income | $24.8 | $15.4 | +61.4% | | GAAP Diluted EPS | $2.07 | $1.69 | +22.5% | | Adjusted Diluted EPS | $1.59 | $0.99 | +60.6% | - Revenue growth was fueled by two main factors: an **8.5%** increase in same-facility net operating revenues and the acquisition of White Oak Management, Inc. on August 1, 2024[1](index=1&type=chunk) - The White Oak acquisition added **22** healthcare operations, including **15** skilled nursing facilities, **2** assisted living facilities, **4** independent living facilities, and a long-term care pharmacy[1](index=1&type=chunk) [Consolidated Financial Statements](index=2&type=section&id=Consolidated%20Financial%20Statements) The Consolidated Statements of Operations for Q1 2025 show a significant increase in income from operations to **$30.8 million**, nearly double the **$15.7 million** from Q1 2024, driven by a **$76.5 million** increase in net patient revenues, partially offset by higher operating costs, particularly a **$45 million** rise in salaries, wages, and benefits, while balance sheet data indicates growth in total assets to **$1.55 billion** and NHC stockholders' equity to over **$1 billion** as of March 31, 2025 Consolidated Statement of Operations Highlights (in thousands) | Account | Q1 2025 ($ thousands) | Q1 2024 ($ thousands) | | :--- | :--- | :--- | | Net Patient Revenues | $361,607 | $285,823 | | Net Operating Revenues | $373,697 | $297,176 | | Total Costs and Expenses | $342,930 | $281,501 | | Income from Operations | $30,767 | $15,675 | | Net Income Attributable to NHC | $32,205 | $26,213 | | Diluted EPS | $2.07 | $1.69 | Selected Balance Sheet Data (in thousands) | Account | March 31, 2025 ($ thousands) | December 31, 2024 ($ thousands) | | :--- | :--- | :--- | | Cash, cash equivalents and marketable securities | $243,171 | $216,185 | | Total Assets | $1,548,821 | $1,524,429 | | NHC Stockholders' Equity | $1,004,895 | $980,161 | - Dividends declared per common share increased to **$0.61** in Q1 2025 from **$0.59** in Q1 2024[7](index=7&type=chunk) [Selected Operating Statistics](index=3&type=section&id=Selected%20Operating%20Statistics) Operating statistics for Q1 2025 reflect broad improvements in the skilled nursing segment, with the average skilled nursing per diem rate rising to **$360.14** from **$343.48** in the prior year, and total skilled nursing patient days increasing significantly to **718,136** from **585,851**, showing notable growth in Medicaid and Managed Care patient days, influenced by both organic growth and acquisitions Skilled Nursing Per Diems (YoY) | Payor Type | Q1 2025 ($) | Q1 2024 ($) | | :--- | :--- | :--- | | Medicare | $612.13 | $581.75 | | Managed Care | $492.40 | $470.56 | | Medicaid | $281.67 | $265.27 | | **Average** | **$360.14** | **$343.48** | Total Skilled Nursing Patient Days (YoY) | Payor Type | Q1 2025 (days) | Q1 2024 (days) | | :--- | :--- | :--- | | Medicare | 86,254 | 81,156 | | Managed Care | 83,646 | 65,431 | | Medicaid | 363,642 | 281,821 | | **Total** | **718,136** | **585,851** | - The year-over-year comparison is impacted by NHC's exit from three skilled nursing facilities in Missouri on March 1, 2024, which accounted for **20,267** patient days in Q1 2024[8](index=8&type=chunk) [GAAP to Non-GAAP Reconciliation](index=3&type=section&id=GAAP%20to%20Non-GAAP%20Reconciliation) The company provides a reconciliation of GAAP to non-GAAP financial measures to offer a clearer view of ongoing operational performance, where for Q1 2025, GAAP net income of **$32.2 million** was adjusted to a non-GAAP net income of **$24.8 million**, primarily by excluding **$11.0 million** in unrealized gains on marketable equity securities and adding back **$1.0 million** in stock-based compensation expense Reconciliation of Net Income (in thousands) | Description | Q1 2025 ($ thousands) | Q1 2024 ($ thousands) | | :--- | :--- | :--- | | **GAAP Net Income** | **$32,205** | **$26,213** | | Unrealized gains on marketable equity securities | ($10,982) | ($14,399) | | Stock-based compensation expense | $1,027 | $793 | | Income tax provision on non-GAAP adjustments | $2,588 | $3,804 | | **Non-GAAP Net Income** | **$24,838** | **$15,386** | Reconciliation of Diluted EPS | Description | Q1 2025 ($) | Q1 2024 ($) | | :--- | :--- | :--- | | **GAAP Diluted EPS** | **$2.07** | **$1.69** | | Unrealized gains on marketable equity securities | ($0.71) | ($0.93) | | Stock-based compensation expense | $0.06 | $0.05 | | Income tax provision on non-GAAP adjustments | $0.17 | $0.25 | | **Non-GAAP Diluted EPS** | **$1.59** | **$0.99** | [Company Overview and Disclosures](index=1&type=section&id=Company%20Overview%20and%20Disclosures) NHC and its affiliates operate a broad portfolio of senior care facilities, including **80** skilled nursing facilities, **26** assisted living communities, and **9** independent living communities, alongside homecare, hospice, and pharmacy services, with the report including standard disclosures explaining the use of non-GAAP financial measures to help investors assess performance consistently and a caution on forward-looking statements, which are subject to risks and uncertainties - NHC affiliates operate **80** skilled nursing facilities (**10,329** beds), **26** assisted living communities (**1,413** units), **9** independent living communities (**777** units), and numerous other healthcare services[3](index=3&type=chunk) - The company presents non-GAAP financial measures because it believes they help investors more accurately assess the ongoing nature of its operations and performance across periods[4](index=4&type=chunk) - The press release contains forward-looking statements that are not guarantees of future performance and involve risks and uncertainties detailed in SEC filings[5](index=5&type=chunk)

[PART I. FINANCIAL INFORMATION](index=4&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) This section details the company's financial statements, management's analysis, market risks, and internal controls [Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements) This section presents the unaudited interim condensed consolidated financial statements, providing a comprehensive view of the company's financial position and performance [Interim Condensed Consolidated Statements of Operations](index=4&type=section&id=Interim%20Condensed%20Consolidated%20Statements%20of%20Operations) NHC reported significant year-over-year growth in Q1 2025, with net operating revenues increasing by 25.7% and income from operations nearly doubling Consolidated Statements of Operations Highlights (in thousands, except per share data) | Metric | Q1 2025 | Q1 2024 | Change (%) | | :--- | :--- | :--- | :--- | | Net Operating Revenues | $373,697 | $297,176 | 25.7% | | Income from Operations | $30,767 | $15,675 | 96.3% | | Net Income Attributable to NHC | $32,205 | $26,213 | 22.9% | | Diluted EPS | $2.07 | $1.69 | 22.5% | [Interim Condensed Consolidated Balance Sheets](index=6&type=section&id=Interim%20Condensed%20Consolidated%20Balance%20Sheets) NHC's balance sheet as of March 31, 2025, shows a slight increase in total assets, stable liabilities, and growth in total equity Consolidated Balance Sheet Summary (in thousands) | Metric | March 31, 2025 | December 31, 2024 | | :--- | :--- | :--- | | Total Current Assets | $455,204 | $424,408 | | Total Assets | $1,548,821 | $1,524,429 | | Total Current Liabilities | $239,225 | $234,797 | | Total Liabilities | $540,839 | $541,266 | | Total Equity | $1,007,982 | $983,163 | [Interim Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Interim%20Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash provided by operating activities surged in Q1 2025, while cash was primarily used for investing and financing activities, including dividends and debt repayment Cash Flow Summary (in thousands) | Cash Flow Activity | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Net Cash from Operating Activities | $39,255 | $9,646 | | Net Cash used in Investing Activities | ($7,323) | ($2,415) | | Net Cash used in Financing Activities | ($12,693) | ($12,067) | | Net Increase/(Decrease) in Cash | $19,239 | ($4,836) | [Notes to Interim Condensed Consolidated Financial Statements](index=10&type=section&id=Notes%20to%20Interim%20Condensed%20Consolidated%20Financial%20Statements) These notes provide detailed explanations of NHC's business operations, accounting policies, and financial statement components, including revenue breakdowns and contingencies - As of March 31, 2025, NHC operates or manages 80 skilled nursing facilities, 26 assisted living facilities, 34 homecare agencies, and 33 hospice agencies, primarily in the southeastern U.S[25](index=25&type=chunk) Net Patient Revenue by Service Type (in thousands) | Service Type | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Inpatient services | $325,478 | $252,254 | | Homecare and hospice services | $36,129 | $33,569 | | **Total** | **$361,607** | **$285,823** | Net Patient Revenue by Payor Source (%) | Payor | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Medicare | 31% | 34% | | Managed Care | 11% | 10% | | Medicaid | 31% | 28% | | Private Pay and Other | 27% | 28% | - The company's subsidiary, Caris Healthcare, L.P., received a Civil Investigative Demand (CID) from the U.S. Attorney's Office in May 2024 related to billing for hospice services from January 1, 2019, and the company is cooperating with the request[118](index=118&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=28&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the strong Q1 2025 performance, attributing it to revenue growth, operational improvements, and a robust liquidity position - Net operating revenues grew **25.7%** year-over-year, primarily due to the White Oak acquisition and an **8.5%** increase in same-facility revenues[158](index=158&type=chunk) - Non-GAAP adjusted net income increased **61.4%** to **$24.8 million** in Q1 2025 from **$15.4 million** in Q1 2024, excluding unrealized gains and other adjustments[159](index=159&type=chunk)[174](index=174&type=chunk) - Agency nurse staffing expense was significantly reduced to **$1.5 million** in Q1 2025 from **$5.3 million** in Q1 2024, indicating improved labor management[165](index=165&type=chunk) - The overall census in owned and leased skilled nursing facilities increased to **89.3%** in Q1 2025 from **88.5%** in Q1 2024[129](index=129&type=chunk) [Results of Operations](index=36&type=section&id=Results%20of%20Operations) Net patient revenues significantly increased in Q1 2025, driven by acquisitions and higher per diem rates, while cost growth was slower, improving operating margins - The White Oak acquisition added **$56.7 million** in net patient revenues and **$37.0 million** in salary expenses in Q1 2025[162](index=162&type=chunk)[166](index=166&type=chunk) Per Diem Rate Increases (Q1 2025 vs. Q1 2024) | Payor | Per Diem Increase (%) | | :--- | :--- | | Medicare | 5.2% | | Managed Care | 4.6% | | Medicaid | 6.2% | | Private Pay | 9.5% | - Other operating expenses increased **19.4%**, but decreased as a percentage of revenue to **24.7%** from **26.1%** in the prior year, indicating improved cost control[167](index=167&type=chunk) [Segment Performance](index=34&type=section&id=Segment%20Performance) The Inpatient Services segment drove significant revenue and income growth, while Homecare and Hospice showed modest growth, and the 'All Other' category reported a larger operating loss Segment Performance (in thousands) | Segment | Net Operating Revenues (Q1 2025) | Income from Operations (Q1 2025) | Net Operating Revenues (Q1 2024) | Income from Operations (Q1 2024) | | :--- | :--- | :--- | :--- | :--- | | Inpatient Services | $325,851 | $32,648 | $252,269 | $14,954 | | Homecare and Hospice | $36,129 | $5,729 | $33,569 | $5,835 | | All Other | $11,717 | ($7,610) | $11,338 | ($5,114) | [Liquidity and Capital Resources](index=39&type=section&id=Liquidity%20and%20Capital%20Resources) NHC maintains a strong liquidity position with substantial cash, marketable securities, and an undrawn credit facility, sufficient to meet obligations and fund growth - Primary sources of cash are from operations, management services, rental income, and investment income[175](index=175&type=chunk) - The company has a **$200 million** credit facility (**$150 million** term, **$50 million** revolver) entered into on August 1, 2024, with no amounts outstanding on the revolver as of March 31, 2025[109](index=109&type=chunk) - Management expects to meet liquidity requirements through cash flow from operations, current cash of **$90.4 million**, unrestricted marketable securities of **$152.8 million**, and borrowing capacity[181](index=181&type=chunk)[182](index=182&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=41&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company's primary market risks are interest rate risk affecting its debt and fixed-income portfolio, and equity price risk, particularly due to a concentrated investment in NHI - The company is exposed to interest rate risk on its **$120.2 million** in available-for-sale marketable debt securities and its variable-rate credit facility tied to SOFR[186](index=186&type=chunk)[188](index=188&type=chunk) - The company faces significant equity price and concentration risk, with **69%** of its **$174.5 million** equity portfolio invested in a single related-party entity, NHI[191](index=191&type=chunk) [Controls and Procedures](index=41&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that the company's disclosure controls and procedures were effective, with no material changes to internal control over financial reporting during the quarter - Management concluded that the Company's disclosure controls and procedures were effective as of March 31, 2025[192](index=192&type=chunk) - No material changes in internal control over financial reporting occurred during the quarter[193](index=193&type=chunk) [PART II. OTHER INFORMATION](index=42&type=section&id=PART%20II.%20OTHER%20INFORMATION) This section provides additional disclosures on legal proceedings, risk factors, and required exhibits [Legal Proceedings](index=42&type=section&id=Item%201.%20Legal%20Proceedings) This section refers to Note 16 for details on material legal proceedings, including a Civil Investigative Demand related to hospice billing practices - For details on legal proceedings, the report directs readers to Note 16 of the Form 10-Q[195](index=195&type=chunk) [Risk Factors](index=42&type=section&id=Item%201A.%20Risk%20Factors) There were no material changes to the risk factors disclosed in the company's Annual Report on Form 10-K for the year ended December 31, 2024 - No material changes to risk factors were reported for the quarter ended March 31, 2025[196](index=196&type=chunk) [Exhibits](index=43&type=section&id=Item%206.%20Exhibits) This section lists the exhibits filed with the Form 10-Q, including certifications by the CEO and CFO, and XBRL data files - The report includes standard exhibits such as CEO/CFO certifications (31.1, 31.2, 32) and Inline XBRL documents (101 series)[200](index=200&type=chunk)

Operations Overview - As of December 31, 2024, the company operates or manages 80 skilled nursing facilities with a total of 10,341 licensed beds, 26 assisted living facilities with 1,413 units, and various other healthcare services across 9 states[184]. - The company expanded its operations by acquiring the White Oak portfolio, which includes 15 skilled nursing facilities and 2 assisted living facilities, adding 1,928 licensed skilled nursing beds[193]. - The company opened several new facilities, including a 135-unit assisted living facility in Vero Beach, FL, and a 66-bed skilled nursing facility in Nashville, TN, in 2023[192]. Financial Performance - For the year ended December 31, 2024, net patient revenues reached $1,111.3 million, an increase from $956.1 million in 2023, representing a growth of approximately 16.2%[199]. - Total costs and expenses for 2024 were $1,221.6 million, leading to an income before income taxes of $136.4 million, compared to $88.7 million in 2023[199]. - GAAP net income attributable to the company was $101,927,000 for 2024, up from $66,798,000 in 2023, while non-GAAP adjusted net income increased to $76,862,000 from $54,934,000[213]. - Net patient revenues reached $1,251,759,000 in 2024, reflecting a $164,145,000 increase, or 15.1%, compared to 2023[215]. - Total net operating revenues and grant income rose to $1,307,382, up 14.56% from $1,141,544 in 2023[288]. - Net income for 2024 reached $102,086 thousand, a significant increase of 56.3% compared to $65,288 thousand in 2023[300]. Revenue Sources - The company recognized $3,266,000 in acquisition-related expenses for the White Oak acquisition in 2024[361]. - Medicare accounted for 33% of the company's net patient revenues in 2024, a decrease from 34% in 2023[370]. - The Company recorded net patient revenues from supplemental Medicaid payments of $12,749,000, $20,214,000, and $19,442,000 for the years ended December 31, 2024, 2023, and 2022, respectively[377]. Cost Management - Salaries, wages, and benefits increased by $98,586,000, or 13.8%, to $810,930,000, representing 62.0% of net operating revenues and grant income[220]. - Total costs and expenses increased by $30,568,000, or 2.9%, to $1,084,410,000 in 2023[238]. - Agency nurse staffing expenses decreased by approximately 44.5%, or $30,682,000, compared to the prior year[239]. Investments and Acquisitions - The company made a substantial acquisition of White Oak Manor for $215,896 thousand in 2024, marking a significant investment in market expansion[300]. - The total estimated fair value of the White Oak acquisition, including goodwill, is $215,905,000[360]. Cash Flow and Assets - Cash provided by operating activities was $107,303,000 in 2024, compared to $111,216,000 in 2023[250]. - Total assets grew to $1,524,429, reflecting an increase of 16.28% from $1,310,796 in 2023[294]. - Cash and cash equivalents decreased to $76,121, down 28.93% from $107,076 in 2023[294]. Compliance and Risk Management - The Company believes it is compliant with all applicable laws and regulations governing Medicare and Medicaid programs[378]. - The company is self-insured for risks related to workers' compensation and general and professional liability insurance, with reserves reassessed quarterly[266]. Market and Economic Factors - The company is actively pursuing partnerships with hospital systems and payors to enhance its position in the post-acute healthcare services market[188]. - A hypothetical 10% change in quoted market prices would result in a related increase or decrease in the fair value of equity investments of approximately $16,325,000[275].

Financial Performance - National HealthCare Corporation reported net operating revenues and grant income of $1,307,382,000 for the year ended December 31, 2024, representing a 14.5% increase from $1,141,544,000 in 2023[1] - The GAAP net income attributable to NHC for 2024 was $101,927,000, up from $66,798,000 in 2023, while adjusted net income increased by 39.9% to $76,862,000[2] - For Q4 2024, the GAAP net income attributable to NHC was $6,081,000, a decrease from $28,406,000 in Q4 2023, but adjusted net income rose 62.7% to $25,954,000[3] - NHC's diluted earnings per share for 2024 were $6.53, up from $4.34 in 2023, reflecting strong earnings growth[2] - The company declared dividends of $2.42 per share for the year ended December 31, 2024, compared to $2.34 in 2023, indicating a commitment to returning value to shareholders[8] Asset Growth - NHC's total assets increased to $1,524,429,000 in 2024 from $1,310,796,000 in 2023, reflecting a significant growth in the company's financial position[9] Operational Expansion - The company acquired White Oak Manor on August 1, 2024, which includes 22 healthcare operations, contributing to the revenue growth[1] - NHC operates 80 skilled nursing facilities with a total of 10,341 beds, alongside various other healthcare services, enhancing its market presence[5] Patient Utilization - The average skilled nursing per diem for Medicare increased to $607.67 in Q4 2024 from $579.84 in Q4 2023, indicating improved revenue per patient[10] - The company reported a total of 728,486 skilled nursing patient days in Q4 2024, compared to 600,510 in Q4 2023, showing a 21.3% increase in patient utilization[10]

Financial Performance - For Q3 2024, National HealthCare Corporation reported net operating revenues of $340,198,000, a 17.9% increase from $288,485,000 in Q3 2023, primarily due to the acquisition of White Oak Manor[1] - GAAP net income attributable to NHC for Q3 2024 was $42,789,000, compared to $10,388,000 in Q3 2023, marking a significant increase[2] - Adjusted net income for Q3 2024 was $19,910,000, up 50.3% from $13,250,000 in Q3 2023[2] - Diluted earnings per share for Q3 2024 were $2.73, compared to $0.68 for Q3 2023, reflecting strong earnings growth[2] - Net income attributable to National Healthcare Corporation for the three months ended September 30, 2024, was $42,789,000, compared to $10,388,000 for the same period in 2023, representing a significant increase[9] - Non-GAAP net income for the nine months ended September 30, 2024, was $50,909,000, up from $38,978,000 for the same period in 2023, indicating a growth of approximately 30%[9] - GAAP diluted earnings per share for the three months ended September 30, 2024, was $2.73, compared to $0.68 for the same period in 2023, reflecting a substantial increase[9] - Non-GAAP diluted earnings per share for the nine months ended September 30, 2024, was $3.27, compared to $2.54 for the same period in 2023, showing an increase of about 28.7%[9] Operational Metrics - The company operates 80 skilled nursing facilities with a total of 10,349 beds, alongside various assisted and independent living communities[4] - Total skilled nursing patient days for Q3 2024 reached 673,378, an increase from 598,938 in Q3 2023[8] - Average skilled nursing per diem for Medicare increased to $578.12 in Q3 2024 from $551.82 in Q3 2023[8] - The company reported operating results for newly opened operations not at full capacity, contributing $120,000 for the three months ended September 30, 2024[9] - The company has two hospice agencies and other healthcare operations that are still in the start-up phase, impacting overall capacity and performance metrics[9] Assets and Dividends - The company’s total assets as of September 30, 2024, were $1,562,707,000, up from $1,310,796,000 in December 2023[7] - NHC declared dividends of $0.61 per common share for Q3 2024, compared to $0.59 in Q3 2023[7] Non-GAAP Measures - The company emphasizes the importance of non-GAAP financial measures to provide a clearer view of its operational performance[5] - Unrealized gains/losses on marketable equity securities for the three months ended September 30, 2024, were $(32,767,000), compared to $3,093,000 for the same period in 2023[9] - Stock-based compensation expense for the three months ended September 30, 2024, was $1,093,000, up from $708,000 for the same period in 2023[9] - Acquisition-related expenses for the three months ended September 30, 2024, were $637,000, while there were no such expenses reported for the same period in 2023[9] - The income tax provision on non-GAAP adjustments for the three months ended September 30, 2024, was $8,038,000, compared to $(1,005,000) for the same period in 2023[9]

Operations and Facilities - As of September 30, 2024, the company operates or manages 80 skilled nursing facilities with a total of 10,349 licensed beds, 26 assisted living facilities with 1,413 units, and 34 homecare agencies[134]. - The overall census in owned and leased skilled nursing facilities for the three months ending September 30, 2024, was 88.3%, an increase from 88.1% for the same period a year ago[137]. - The company has 45 skilled nursing facilities rated 4 and 5 stars, representing 56% of its total facilities, compared to 36% in the industry[140]. - The average census at owned and leased skilled nursing facilities for the nine months ended September 30, 2024, was 88.6%, up from 87.8% in the same period last year[188]. Financial Performance - The Company reported net patient revenues of $328,674,000 for inpatient services and $35,648,000 for homecare and hospice services, totaling $340,198,000[161]. - Total costs and expenses for the Company amounted to $319,151,000, resulting in an income from operations of $21,047,000[161]. - For the three months ended September 30, 2023, net patient revenues were $277,005,000, with total costs and expenses of $275,460,000, leading to an income from operations of $13,025,000[162]. - The Company reported net patient revenues of $894,415,000 for inpatient services and $103,751,000 for homecare and hospice services, totaling $938,032,000[163]. - For the nine months ended September 30, 2023, net patient revenues were $804,617,000, with total costs and expenses of $803,616,000, resulting in an income from operations of $37,014,000[164]. - For the three months ended September 30, 2024, GAAP net income attributable to the company was $42,789,000, a significant increase from $10,388,000 in the same period of 2023, representing a 312.5% growth[171]. - Net operating revenues for the quarter increased by $51,669,000, or 18.7%, compared to the same period last year[173]. - The total costs and expenses for the three months ended September 30, 2024, increased by $43,691,000, or 15.9%, totaling $319,151,000 compared to $275,460,000 in 2023[178]. - Adjusted net income for the nine months ended September 30, 2024, was $50,909,000, compared to $38,978,000 for the same period in 2023, reflecting a 30.5% increase[185]. Revenue Sources and Changes - The average Medicare per diem rate for skilled nursing facilities increased by 4.9% for the first nine months of 2024 compared to the same period in 2023[148]. - The average Medicaid per diem increased by 10.2% for the first nine months of 2024 compared to the same period in 2023[152]. - The state of Tennessee's Medicaid increases are estimated to result in an additional revenue of approximately $11 million annually, or $2.75 million per quarter, starting from fiscal year 2025[148]. - The acquisition of the White Oak portfolio on August 1, 2024, contributed an increase of $37,299,000 in net patient revenues for the quarter ended September 30, 2024[175]. - Net patient revenues increased by $37,299,000 due to the acquisition of White Oak on August 1, 2024[189]. Cost Management - Salaries, wages, and benefits as a percentage of net operating revenues decreased from 63.3% in 2023 to 62.7% in 2024[179]. - The company experienced a 60% reduction in agency staffing expenses for the three months ended September 30, 2024, compared to the same period in 2023[179]. - Salaries, wages, and benefits as a percentage of net operating revenues decreased to 61.5% from 62.5% year-over-year[194]. - Total costs and expenses rose by $75,220,000, or 9.4%, to $878,836,000 for the nine months ended September 30, 2024[193]. Tax and Cash Flow - The effective income tax rate for the three months ended September 30, 2024, was 26.4%, with a provision of $15,338,000[184]. - The effective income tax rate for the nine months ended September 30, 2024, was 26.3%, with an income tax provision of $34,294,000[199]. - Net cash provided by operating activities was $94,514,000, an increase of 10.6% compared to $85,483,000 in the same period last year[202]. - Net cash used in investing activities totaled $225,048,000, a significant increase from $7,382,000 in the prior year[204]. - Net cash provided by financing activities was $119,640,000, compared to net cash used of $32,711,000 in the same period last year[205]. Market and Regulatory Changes - In fiscal year 2025, CMS projects a 1.7% decrease in payments to home health agencies, equating to a reduction of $280 million compared to the previous year[155]. - For fiscal year 2024, CMS issued a 3.1% rate increase for hospice services, amounting to $780 million, effective October 1, 2023[157]. - In fiscal year 2025, CMS announced a 2.9% rate increase for hospice services, totaling $790 million, effective October 1, 2024[158]. Non-GAAP Financial Measures - The Company provides non-GAAP financial measures to help investors assess ongoing operations and performance consistency across periods[165]. - The Company believes that excluding unrealized gains or losses on marketable equity securities and other specific items provides a clearer view of operational performance[166]. Marketable Securities - The fair value of marketable equity securities was approximately $187,755,000 as of September 30, 2024, with unrealized gains of $139.9 million[215].

Operations Overview - As of June 30, 2024, the company operates or manages 65 skilled nursing facilities with a total of 8,421 licensed beds, 24 assisted living facilities with 1,365 units, and 34 homecare agencies[110]. - The overall census in owned and leased skilled nursing facilities for the three months ending June 30, 2024, was 89.0%, up from 87.9% for the same period a year ago[112]. - The overall census in owned and leased skilled nursing facilities for the six months ending June 30, 2024, was 88.7%, compared to 87.7% for the same period a year ago[112]. - The company has 62% of its skilled nursing facilities rated 4 and 5 stars, compared to 36% for the industry average[115]. - The company purchased the White Oak portfolio, which includes six skilled nursing facilities and totals 1,928 licensed beds[117]. Financial Performance - The Company reported net patient revenues of $245,385 thousand for inpatient services and $34,533 thousand for homecare and hospice for the three months ended June 30, 2024, totaling $279,918 thousand[131]. - Total costs and expenses for the Company were $278,138 thousand for the three months ended June 30, 2024, resulting in income from operations of $22,520 thousand[131]. - For the six months ended June 30, 2024, the Company reported net patient revenues of $497,638 thousand for inpatient services and $68,103 thousand for homecare and hospice, totaling $565,741 thousand[133]. - The Company’s total costs and expenses for the six months ended June 30, 2024, were $559,685 thousand, leading to income from operations of $38,149 thousand[133]. - The Company’s non-operating income for the three months ended June 30, 2024, was $4,956 thousand, contributing to income before income taxes of $36,600 thousand[131]. - For the three months ended June 30, 2024, GAAP net income attributable to the company was $26,844,000, a 64.5% increase from $16,281,000 in the same period of 2023[139]. - Adjusted net income for the quarter ended June 30, 2024 was $15,612,000, compared to $13,658,000 for the same period in 2023, reflecting a 14.3% increase[139]. - For the six months ended June 30, 2024, GAAP net income attributable to the company was $53,057,000, compared to $28,004,000 for the same period in 2023, representing an increase of 89.4%[149]. - Net patient revenues for the six months ended June 30, 2024 increased by $38,129,000, or 7.2%, compared to the same period last year[151]. Revenue Sources and Changes - The company recorded $2,585,000 in net patient revenues from supplemental Medicaid payments for the three months ended June 30, 2024[124]. - New operations contributed an increase of $9,803,000 in net patient revenues for the six months ended June 30, 2024, compared to the same period in the prior year[152]. - The company exited operations of two skilled nursing facilities and one memory care facility, resulting in a decrease of $10,869,000 in net patient revenues for the six months ended June 30, 2024[154]. - Other revenues decreased by $1,885,000, or 7.7%, compared to the same period last year[154]. Cost Management - Total costs and expenses increased by $31,529,000, or 6.0%, to $559,685,000 for the six months ended June 30, 2024, compared to $528,156,000 in the prior year[154]. - Total costs and expenses for the three months ended June 30, 2024 increased by $9,533,000, or 3.5%, to $278,138,000 from $268,605,000[145]. - Salaries, wages, and benefits as a percentage of net operating revenues decreased to 59.9% from 62.0% for the three months ended June 30, 2023[145]. - Salaries, wages, and benefits as a percentage of net operating revenues decreased to 60.8% for the six months ended June 30, 2024, from 62.1% in the prior year[155]. - Agency staffing expense decreased approximately 54% for the six months ended June 30, 2024, compared to the same period in 2023[155]. Medicare and Medicaid Impact - The average Medicare per diem rate for skilled nursing facilities increased by 5.0% for the first six months of 2024 compared to the same period in 2023[122]. - The fiscal year 2024 Medicare payment rates for skilled nursing facilities will see a net increase of 4.0%, approximately $1.4 billion, compared to 2023 levels[119]. - The state of Tennessee's individual nursing facility increases are estimated to result in an additional revenue of approximately $11 million annually for fiscal year 2025[122]. - In fiscal year 2025, CMS projects a decrease of 1.7% or $280 million in payments to home health agencies compared to the previous year[127]. - For fiscal year 2024, CMS issued a hospice payment rate increase of 3.1%, amounting to $780 million, effective October 1, 2023[127]. - For fiscal year 2025, CMS announced a hospice payment rate increase of 2.9%, totaling $790 million, effective October 1, 2024[128]. Cash Flow and Liquidity - Net cash provided by operating activities was $60,307,000 for the six months ended June 30, 2024, compared to $53,178,000 in the same period last year[161]. - Cash, cash equivalents, and restricted cash at the end of the period increased by 60.9% to $165,605,000 from $102,905,000[160]. - The company expects to meet short-term liquidity requirements primarily from cash flows from operating activities and a new $200 million credit facility effective August 1, 2024[164]. Marketable Securities - The fair value of marketable equity securities was approximately $154,883,000 as of June 30, 2024, with net unrealized gains of $107.1 million[170]. - As of June 30, 2024, the fair value of the company's marketable equity securities is approximately $154.9 million[170]. - The investment in NHI comprises approximately $110.4 million, or 71.3%, of the total fair value of the equity securities portfolio[170]. - A hypothetical 10% change in quoted market prices would result in a related increase or decrease in the fair value of equity investments of approximately $15.5 million[170]. - The company's equity securities had net unrealized gains of $107.1 million as of June 30, 2024[170]. - Of the $107.1 million in unrealized gains, $85.7 million is related to the investment in NHI[170]. Non-GAAP Financial Measures - The Company emphasizes the importance of non-GAAP financial measures to provide a clearer assessment of ongoing operations and performance consistency across periods[135]. - The Company believes that excluding unrealized gains or losses on marketable equity securities and other specific items in non-GAAP measures helps investors assess operations more accurately[136].

Financial Performance - Net operating revenues for Q1 2024 totaled $297,176,000, an increase of 10.2% compared to $269,563,000 in Q1 2023[1] - GAAP net income attributable to NHC was $26,213,000 for Q1 2024, up from $11,723,000 in Q1 2023, representing a growth of 123.3%[2] - Adjusted net income for Q1 2024 was $15,048,000, a 24.7% increase from $12,071,000 in Q1 2023[2] - GAAP diluted earnings per share rose to $1.69 in Q1 2024 from $0.76 in Q1 2023, while adjusted diluted earnings per share increased to $0.97 from $0.79[2] Operational Metrics - Total skilled nursing patient days increased to 585,851 in Q1 2024 from 576,406 in Q1 2023[9] - Average skilled nursing per diem increased to $343.48 in Q1 2024 from $315.81 in Q1 2023[9] - NHC operates 65 skilled nursing facilities with 8,421 beds and 24 assisted living communities with 1,365 units[4] Assets and Cash Position - Cash, cash equivalents, and marketable securities totaled $217,506,000 as of March 31, 2024, down from $223,620,000 at the end of 2023[8] - Total assets increased to $1,319,640,000 as of March 31, 2024, from $1,310,796,000 at the end of 2023[8] Dividends - The company declared dividends of $0.59 per common share for Q1 2024, compared to $0.57 in Q1 2023[8]